These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28134751)

  • 1. Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model.
    Moxley RA; Francis DH; Tamura M; Marx DB; Santiago-Mateo K; Zhao M
    Toxins (Basel); 2017 Jan; 9(2):. PubMed ID: 28134751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.
    Mukherjee J; Chios K; Fishwild D; Hudson D; O'Donnell S; Rich SM; Donohue-Rolfe A; Tzipori S
    Infect Immun; 2002 Feb; 70(2):612-9. PubMed ID: 11796590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications.
    Sheoran AS; Chapman-Bonofiglio S; Harvey BR; Mukherjee J; Georgiou G; Donohue-Rolfe A; Tzipori S
    Infect Immun; 2005 Aug; 73(8):4607-13. PubMed ID: 16040972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.
    Sheoran AS; Dmitriev IP; Kashentseva EA; Cohen O; Mukherjee J; Debatis M; Shearer J; Tremblay JM; Beamer G; Curiel DT; Shoemaker CB; Tzipori S
    Infect Immun; 2015 Jan; 83(1):286-91. PubMed ID: 25368111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.
    Baker DR; Moxley RA; Steele MB; Lejeune JT; Christopher-Hennings J; Chen DG; Hardwidge PR; Francis DH
    Appl Environ Microbiol; 2007 Nov; 73(22):7338-46. PubMed ID: 17890332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
    Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2.
    Donohue-Rolfe A; Kondova I; Oswald S; Hutto D; Tzipori S
    J Infect Dis; 2000 May; 181(5):1825-9. PubMed ID: 10823794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity.
    Albanese A; Sacerdoti F; Seyahian EA; Amaral MM; Fiorentino G; Fernandez Brando R; Vilte DA; Mercado EC; Palermo MS; Cataldi A; Zotta E; Ibarra C
    Vaccine; 2018 Mar; 36(13):1728-1735. PubMed ID: 29483033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of pregnant cows with EspA, EspB, γ-intimin, and Shiga toxin 2 proteins from Escherichia coli O157:H7 induces high levels of specific colostral antibodies that are transferred to newborn calves.
    Rabinovitz BC; Gerhardt E; Tironi Farinati C; Abdala A; Galarza R; Vilte DA; Ibarra C; Cataldi A; Mercado EC
    J Dairy Sci; 2012 Jun; 95(6):3318-26. PubMed ID: 22612965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing activity of bovine colostral antibody against verotoxin derived from enterohemorrhagic Escherichia coli O157:H7 in mice.
    Kuribayashi T; Seita T; Fukuyama M; Furuhata K; Honda M; Matsumoto M; Seguchi H; Yamamoto S
    J Infect Chemother; 2006 Oct; 12(5):251-6. PubMed ID: 17109087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits.
    Ritchie JM; Thorpe CM; Rogers AB; Waldor MK
    Infect Immun; 2003 Dec; 71(12):7129-39. PubMed ID: 14638803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gnotobiotic piglet infection model for evaluating the safe use of antibiotics against Escherichia coli O157:H7 infection.
    Zhang Q; Donohue-Rolfe A; Krautz-Peterson G; Sevo M; Parry N; Abeijon C; Tzipori S
    J Infect Dis; 2009 Feb; 199(4):486-93. PubMed ID: 19125676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli.
    Gunzer F; Hennig-Pauka I; Waldmann KH; Sandhoff R; Gröne HJ; Kreipe HH; Matussek A; Mengel M
    Am J Clin Pathol; 2002 Sep; 118(3):364-75. PubMed ID: 12219778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering an anti-Stx2 antibody to control severe infections of EHEC O157:H7.
    Ma Y; Mao X; Li J; Li H; Feng Y; Chen H; Luo P; Gu J; Yu S; Zeng H; Guo G; Yang K; Zou Q
    Immunol Lett; 2008 Dec; 121(2):110-5. PubMed ID: 19007817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of O157:H7 Escherichia coli infection in neonatal calves.
    Dean-Nystrom EA; Bosworth BT; Moon HW
    Adv Exp Med Biol; 1997; 412():47-51. PubMed ID: 9191989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2.
    Donohue-Rolfe A; Kondova I; Mukherjee J; Chios K; Hutto D; Tzipori S
    Infect Immun; 1999 Jul; 67(7):3645-8. PubMed ID: 10377152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of postinfection treatment with anti-Shiga toxin (Stx) 2 humanized monoclonal antibody TMA-15 in mice lethally challenged with Stx-producing Escherichia coli.
    Yamagami S; Motoki M; Kimura T; Izumi H; Takeda T; Katsuura Y; Matsumoto Y
    J Infect Dis; 2001 Sep; 184(6):738-42. PubMed ID: 11517435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction and immunization of a enterohemorrhagic Escherichia coli O157 attenuated].
    Liu J; Sun Y; Feng SZ
    Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):211-7. PubMed ID: 17460890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves.
    Dean-Nystrom EA; Bosworth BT; Cray WC; Moon HW
    Infect Immun; 1997 May; 65(5):1842-8. PubMed ID: 9125570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.